CDKN2A and head and neck squamous cell carcinoma: The cuproptosis-related gene CDKN2A is associated with the malignant behavior of head and neck squamous cell carcinoma (HNSCC), and plicamycin inhibits the progression of HNSCC, indicating its potential as a cuproptosis inducer (Fan et al. 2022).